Katrine Farstad eier aksjer i 2 selskaper.
- Selskap
- Privatpersoner
- Utenlandsk
Katrine Farstad
Lille Trollbu AS
100 %
Ask AS
39,7 %
Saf Invest II AS
75 %
Sverre Farstad & Co AS
100 %
Spesialistbedriften AS
0,2 %
OWI-SUB1 AS
100 %
Norwind Shipholding AS
35,1 %
Norwind Breeze AS
100 %
Norwind Storm AS
100 %
Norwind Hurricane AS
100 %
Norwind Helm AS
100 %
Norwind Gale AS
100 %
Norwind Crewing AS
100 %
Tyrholm & Farstad AS
53,5 %
Grimmergata 5 AS
100 %
Skansekaia Utvikling AS
33,3 %
Offshore Wind Investor AS
10,8 %
OWI-SUB1 AS
100 %
Norwind Shipholding AS
35,1 %
Norwind Breeze AS
100 %
Norwind Storm AS
100 %
Norwind Hurricane AS
100 %
Norwind Helm AS
100 %
Norwind Gale AS
100 %
Norwind Offshore AS
5,4 %
Norwind Crewing AS
100 %
Ålesund Stadion AS
3,1 %
Ålesund Storhall AS
27,4 %
Ålesund Fotball AS
<0,1 %
Ålesund Stadion II AS
2,7 %
Ålesund Storhall AS
27,4 %
Ålesund Fotball AS
<0,1 %
Ålesund Storhall AS
<0,1 %
Ålesund Storhall AS
2,3 %
Ålesund Stadion AS
2,1 %
Ålesund Stadion II AS
1,6 %
Ålesund Storhall AS
27,4 %
Ålesund Fotball AS
<0,1 %
Ålesund Storhall AS
0,6 %
Spesialistbedriften AS
1,7 %
Ava Ocean Holding AS
<0,1 %
Ava Ocean AS
100 %
Ava Ocean Technology AS
100 %
OWI-SUB1 AS
100 %
Norwind Shipholding AS
35,1 %
Norwind Breeze AS
100 %
Norwind Storm AS
100 %
Norwind Hurricane AS
100 %
Norwind Helm AS
100 %
Norwind Gale AS
100 %
Spesialistbedriften AS
4,3 %
Norwind Offshore AS
2,7 %
Norwind Crewing AS
100 %
Bagid AS
1,5 %
Ava Ocean Holding AS
0,2 %
Ava Ocean AS
100 %
Ava Ocean Technology AS
100 %
Ro Legacy AS
0,1 %
Formue AS
<0,1 %
Formue Accounting AS
100 %
Formuesforvaltning AS
100 %
Formue Norge AS
100 %
Fo Private Equity 2011 AS
22,2 %
Tekna Holding ASA
<0,1 %
Formue Private Equity AS
100 %
Attivo Eiendomsutvikling AS
40,9 %
Norinnova Invest AS
15,2 %
Prophylix Pharma Holding AS
31,4 %
Prophylix AS
100 %
Calanus AS
3,2 %
Salgard AS
100 %
Zooca Calanus AS
100 %
Lyfstone AS
2,9 %
Lyfstone AS
1,2 %
Lyfstone Invest AS
1,1 %
Lytix Biopharma ASA
0,8 %
Lyfstone Invest AS
0,7 %
Amicoat AS
0,5 %
Peptide Patents AS
50 %
Pharma Holdings AS
0,4 %
Peptide Patents AS
50 %
Formue AS
0,5 %